Humalog is a new type of Insulin sold by Eli Lilly. Humalog starts to work approximately after you inject it. Humalog has been designed to work similar to the human bodies own insulin. With this new type of insulin, you can inject and eat right away OR eat then inject. This is an exellent insulin for those of you that are picky eaters or have busy schedules. Humalog is the insulin that works in real life.
Humalog is the best for people who want to improve the control of their blood sugars and lower their HbAc's (Glycoslated Hemoglobin A1c). It is also better for people who want to lead a more flexible life.
Humalog has been designed to work fast and to somewhat mimic the bodies own insulin, providing advantages to your daily life. First off, you no longer have to wait 30-45 minutes as with Toronto (Regular) Insulin. Humalog allows you to inject your insulin and eat right away.
If you are presently using Humalog or are planning on switching to it, you should remember or take into
consideration the following tips.
Humalog was discovered and developed be a scientist who found that the absorption of insuulin injected under the skin could be accelerated by changing the order of two amino acids in the human insulin molecule. Humalog is designed more closely to mimic the body's own natural output in response to eating a meal.
More that 16 million people in the United States suffer from diabetes, it is the fourth-leading cause of death each year. In the U.S. alone, the disease costs society some $92 billion each year, according to the American Diabetes Association
People with diabetes have to monitor blood-glucose levels and sometimes inject insulin several times a day to help their bodies process food. For people at who are using regular human insulin, helath care professionals recommend that injections be timed t least 30 to 45 minutes prior to a meal to allow the medication to begin working.
A 1995 survey of 453 insulin-using patients with Type I and Type II Diabetes showed that 43% injected insulin closer to their meals than recommended. Only 25% of the patients surveyed took their insulin more that 30 minutes before they ate. Taking insulin too close to a meal can increase a patient's risk of hyperglycemia (high blood sugar) shortly after the meal, and hypoglycemia (low blood sugar) before the next meal.
The approval of Humalog was based on data from worldwide clinical studies that included approximately 3000 patients who were evaluated over 3 years. Diabetics who participated in clincal trials injected Humalog within 15 minutes of eating a meal instead of injecting regular human insulin between 20 and 35 minutes before. Clinical trial evidence showed that Humalog acted faster then regular human insulin to control blood-glucose levels after a meal.
Humalog, an insulin analog of recombiant DNA origin, has been approved for the treatment of Type I and Type II Diabetes. Humalog is the first of a new type of insulin that is designed to mimic the body's own normal rapid insulin response.